Robert J Gould - Net Worth and Insider Trading
Robert J Gould Net Worth
The estimated net worth of Robert J Gould is at least $2 Million dollars as of 2025-04-24. Robert J Gould is the Interim President & CEO of Fulcrum Therapeutics Inc and owns about 499,864 shares of Fulcrum Therapeutics Inc (FULC) stock worth over $2 Million. Robert J Gould is also the Director of Epizyme Inc and owns about 0 shares of Epizyme Inc (EPZM) stock worth over $0. Details can be seen in Robert J Gould's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert J Gould has not made any transactions after 2023-01-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert J Gould
Robert J Gould Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert J Gould owns 3 companies in total, including Fulcrum Therapeutics Inc (FULC) , Epizyme Inc (EPZM) , and Turnstone Biologics Corp (TSBX) .
Click here to see the complete history of Robert J Gould’s form 4 insider trades.
Insider Ownership Summary of Robert J Gould
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FULC | Fulcrum Therapeutics Inc | 2023-01-13 | director & President & CEO |
| EPZM | Epizyme Inc | 2015-12-30 | director & 10 percent owner & President and CEO |
| TSBX | Turnstone Biologics Corp | 2023-07-20 | director |
Robert J Gould Latest Holdings Summary
Robert J Gould currently owns a total of 2 stocks. Among these stocks, Robert J Gould owns 499,864 shares of Fulcrum Therapeutics Inc (FULC) as of January 13, 2023, with a value of $2 Million and a weighting of 100%. Robert J Gould also owns 0 shares of Epizyme Inc (EPZM) as of December 30, 2015, with a value of $0 and a weighting of 0%.
Latest Holdings of Robert J Gould
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FULC | Fulcrum Therapeutics Inc | 2023-01-13 | 499,864 | 3.59 | 1,794,512 |
| EPZM | Epizyme Inc | 2015-12-30 | 0 | 1.47 | 0 |
Holding Weightings of Robert J Gould
Robert J Gould Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert J Gould has made a total of 16 transactions in Fulcrum Therapeutics Inc (FULC) over the past 5 years, including 0 buys and 16 sells. The most-recent trade in Fulcrum Therapeutics Inc is the sale of 6,766 shares on January 13, 2023, which brought Robert J Gould around $101,490.
According to the SEC Form 4 filings, Robert J Gould has made a total of 0 transactions in Epizyme Inc (EPZM) over the past 5 years. The most-recent trade in Epizyme Inc is the sale of 32,108 shares on December 30, 2015, which brought Robert J Gould around $578,265.
Insider Trading History of Robert J Gould
- 1
Robert J Gould Trading Performance
Robert J Gould Ownership Network
Ownership Network List of Robert J Gould
Ownership Network Relation of Robert J Gould
Robert J Gould Owned Company Details
What does Fulcrum Therapeutics Inc do?
Who are the key executives at Fulcrum Therapeutics Inc?
Robert J Gould is the director & President & CEO of Fulcrum Therapeutics Inc. Other key executives at Fulcrum Therapeutics Inc include Controller Greg Tourangeau , director & See Remarks Alex Sapir , and Chief Financial Officer Alan A Musso .
Fulcrum Therapeutics Inc (FULC) Insider Trades Summary
Over the past 18 months, Robert J Gould made no insider transaction in Fulcrum Therapeutics Inc (FULC). Other recent insider transactions involving Fulcrum Therapeutics Inc (FULC) include a net sale of 5,120 shares made by Greg Tourangeau , and a net purchase of 43,360 shares made by Alex Sapir .
In summary, during the past 3 months, insiders sold 0 shares of Fulcrum Therapeutics Inc (FULC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,120 shares of Fulcrum Therapeutics Inc (FULC) were sold and 43,360 shares were bought by its insiders, resulting in a net purchase of 38,240 shares.
Fulcrum Therapeutics Inc (FULC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fulcrum Therapeutics Inc Insider Transactions
Robert J Gould Mailing Address
Above is the net worth, insider trading, and ownership report for Robert J Gould. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Robert J Gould's mailing address is: Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
